To view this email as a web page, click here.
 
 
Can Antibiotic Therapy for Cancer Improve Treatment Response to Immune Checkpoint Inhibitors?
A new study looked at median overall survival for patients with prior antibiotic therapy compared with patients with no prior antibiotic therapy.
Read more
 
Hemithyroidectomy Rates Increase Following Guideline Change
In late 2015, the American Thyroid Association (ATA) changed guideline recommendations trying to rein in overly aggressive treatment of thyroid cancers that are low risk, offering the choice of hemithyroidectomy as an alternative to total thyroidectomy in these patients. In participating hospitals, the rates of hemithyroidectomy went up.
Read more
 
 
IN CASE YOU MISSED IT
 
Camrelizumab Plus Chemo Considered as New First-Line Therapy
Findings from the upcoming International Association for the Study of Lung Cancer 2019 World Conference on Lung Cancer show camrelizumab and chemotherapy showed survival benefits for patients with metastatic or otherwise advanced non-squamous non–small-cell lung cancer.
Read more
ADVERTISEMENT
Liquid Test, Solid Answers

FoundationOne®Liquid can deliver reliable answers faster than tissue testing by analyzing 70 genes and reporting on microsatellite instability high (MSI-H) status from a simple blood draw.

AdvertisementRead more.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.